The corporate venture capital arm of Covid-19 vaccine maker Pfizer has co-led a $49m (£39.6m) investment into Oxford-based biotech startup Grey Wolf, which develops immuno-oncology...
Biotech startup Nucleome Therapeutics has raised £37.5m in an oversubscribed Series A round to discover new medicines by decoding the human genome. The investment will...
US biopharmaceutical company Gilead Sciences is acquiring Oxford-based biotech startup MiroBio in a cash deal valued at approximately $405m (£333.9m). Spun out of the University...